Moomoo AI 已提取核心信息
On February 28, 2024, 180 Life Sciences Corp. reported the exercise of pre-funded warrants by a holder, resulting in the purchase of 64,684 shares of common stock at $0.0019 per share, amounting to $122.90 in cash. This transaction followed a 1-for-19 reverse stock split effective on the same date, as previously disclosed in a Current Report on Form 8-K filed with the SEC. The shares from the warrant exercise are to be issued and were exempt from registration under Section 4(a)(2) of the Securities Act, with their resale registered under a registration statement declared effective under the Securities Act. Post-issuance, the company's issued and outstanding common stock will total approximately 652,292 shares, not accounting for rounding from the reverse stock split. The report was signed by CEO James N. Woody, M.D., Ph.D., on March 1, 2024.
On February 28, 2024, 180 Life Sciences Corp. reported the exercise of pre-funded warrants by a holder, resulting in the purchase of 64,684 shares of common stock at $0.0019 per share, amounting to $122.90 in cash. This transaction followed a 1-for-19 reverse stock split effective on the same date, as previously disclosed in a Current Report on Form 8-K filed with the SEC. The shares from the warrant exercise are to be issued and were exempt from registration under Section 4(a)(2) of the Securities Act, with their resale registered under a registration statement declared effective under the Securities Act. Post-issuance, the company's issued and outstanding common stock will total approximately 652,292 shares, not accounting for rounding from the reverse stock split. The report was signed by CEO James N. Woody, M.D., Ph.D., on March 1, 2024.
2024年2月28日，180生命科学公司报告称，持有人行使了预先注资的认股权证，结果以每股0.0019美元的价格购买了64,684股普通股，总额为122.90美元的现金。正如先前在向美国证券交易委员会提交的8-K表最新报告中披露的那样，该交易是在同日生效的1比19的反向股票拆分之后进行的。根据《证券法》第4（a）（2）条，认股权证行使中的股票将发行且免于注册，其转售是根据证券法宣布生效的注册声明进行的。发行后，该公司的已发行和流通普通股总额将约为652,292股，不包括反向股票拆分的四舍五入。该报告由首席执行官詹姆斯·伍迪医学博士、博士于2024年3月1日签署。
2024年2月28日，180生命科学公司报告称，持有人行使了预先注资的认股权证，结果以每股0.0019美元的价格购买了64,684股普通股，总额为122.90美元的现金。正如先前在向美国证券交易委员会提交的8-K表最新报告中披露的那样，该交易是在同日生效的1比19的反向股票拆分之后进行的。根据《证券法》第4（a）（2）条，认股权证行使中的股票将发行且免于注册，其转售是根据证券法宣布生效的注册声明进行的。发行后，该公司的已发行和流通普通股总额将约为652,292股，不包括反向股票拆分的四舍五入。该报告由首席执行官詹姆斯·伍迪医学博士、博士于2024年3月1日签署。
有用
没用